FDA Seeks Diabetes Warning on
Anti-Psychotic Drugs
Sept. 17, 2003 -
FDA regulators have requested that six of the most widely used
anti-psychotic drugs carry a warning that they can increase
the risk of elevated blood sugar and diabetes, according to a
news release by Eli Lilly and Co.
Lilly, which makes the top-selling
schizophrenia treatment Zyprexa, said the FDA
is also seeking the warning on the product labeling for
Johnson & Johnson's rival Risperdal, Novartis AG's Clozaril,
Bristol-Myers Squibb Co.'s Abilify, AstraZeneca Plc's Seroquel
and Pfizer Inc.'s Geodon.
More> 3/17/03*
Pioglitazone and Rosiglitazone
Two commonly
prescribed diabetes drugs may cause heart failure and fluid buildup
Sept. 9, 2003 - Two diabetes medications taken by
more than 6 million Americans may lead to serious side effects,
including the onset of congestive heart failure and pulmonary edema,
according to researchers at UT Southwestern Medical Center at
Dallas. More>
Diabetes, Heart Failure Patients Often Treated with Diabetes
Medications Considered Unsafe
Yale and Denver Health Medical Researchers Report
New
Haven, Conn., July 16, 2003 -- In a national study of diabetic
patients hospitalized with heart failure, researchers from Yale
University and Denver Health Medical Center found that more than a
quarter are treated with diabetes medications not considered safe by
the United States Food and Drug Administration (FDA).
More> 7/16/03*
